Scientists Discover Antibodies Neutralizing Measles Virus

In May 2026, scientists identified human antibodies capable of neutralizing the measles virus, opening possibilities for new preventive and therapeutic treatments.

Key Points

Major Discovery:
- Human antibodies can block measles virus infection.
- Antibodies attach to critical sites on the virus.
Mechanism of Action:
- Antibodies target measles fusion protein and “H” attachment protein.
- Prevent virus from entering host cells.
Research Method:
- Scientists used cryo-electron microscopy.
- Enabled detailed 3D imaging of antibody-virus interaction.
Key Findings:
- Antibodies isolated from vaccinated woman’s blood.
- Effective both before and after viral exposure.
- Reduced viral load by nearly 500-fold in rodent studies.
Notable Antibody: Antibody “3A12” made circulating virus undetectable.
Potential Applications:
- Could become first pre- or post-exposure measles treatment.
- Especially useful for immunocompromised individuals and unvaccinated children.
Public Health Relevance:
- Important amid rising vaccine hesitancy and measles outbreaks.
- Supports populations lacking herd immunity protection.